FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379283385> ?p ?o ?g. }

• W4379283385 endingPage "e15155" @default.
• W4379283385 startingPage "e15155" @default.
• W4379283385 abstract "e15155 Background: HCC is one of the leading causes of cancer deaths worldwide. Despite increasing systemic therapy options for patients with advanced HCC, there are currently no predictive biomarkers to guide therapy selection. Phosphoproteomics has been successfully used to identify accurate predictive biomarkers in other cancers from frozen clinical samples (Dokal et al., 2021 ASCO Annual Meeting). In this study, we test the feasibility of biomarker discovery using phospho- and whole-proteomics analyses on formalin fixed and paraffin embedded (FFPE) tru-cut liver biopsies from patients with HCC. Methods: FFPE tru-cut biopsies (n = 29) were obtained from separate cohorts of 15 HCC patients [tumor (T)] and 14 patients with chronic liver disease with varying levels of cirrhosis, fibrosis or steatosis but without cancer [non-tumor (NT)]. T samples were from advanced HCC patients with varied aetiology (chronic viral hepatitis, alcohol or NAFLD). Proteins were extracted from 10 x 10µm sections; crosslinks reversed before digestion to peptides; and multiple clean-up/enrichment steps before analysis. Peptides were quantified by mass spectrometry and performance assessed using multi-variate and enrichment analyses. Results: Overall, 4978 phosphopeptides and 3721 proteins were quantified across all samples. Multi-variate analyses based on the relative expression of phosphopeptides or proteins showed a clear separation between T and NT samples, as well as phenotype-distinct separation (i.e according to differentiation) within the T group. Subsequent testing also verified that the method could reproducibly measure these HCC-differentiating phosphorylation sites (and proteins). Proteins associated with HCC were regulated as expected in T vs NT, e.g. ASS1 (log2-fold change (FC) = -1.75, p < 0.001), BDH2 (log2-FC = -1.97, p < 0.001). Known drug targets were found to be significantly upregulated in poorly-differentiated HCC, e.g. PARP1 (log2-FC = 1.7, p < 0.001) and AKT1 (log2-FC = 1.5, p < 0.001), as well as previously described phosphorylation sites, e.g. p-CDK1 T14 (log2-FC = 5.95, p = 0.007) and p-MCM2 S139 (log2-FC = 2.98, p = 0.046). Kinase substrate enrichment analysis (Casado et al., Science Signaling 2013) showed increased activity for several kinases in T vs NT, including A-RAF (z-score = 3.2, p < 0.001), MAPK3 (z-score = 2.1, p = 0.022) and TNK2 (z-score = 2.1, p = 0.003). Conclusions: We successfully adapted (phospho-)proteomics to FFPE tru-cut biopsy specimens, enabling reproducible identification of novel and known (phospho-)proteins that distinguished differentiation status. A prospective study utilising this phosphoproteomic analysis pipeline is now underway, recruiting patients with advanced HCC receiving first line standard of care therapy with immune checkpoint inhibitor combinations or tyrosine kinase inhibitors to identify potential predictive biomarkers of response." @default.
• W4379283385 created "2023-06-05" @default.
• W4379283385 creator A5007831616 @default.
• W4379283385 creator A5017359496 @default.
• W4379283385 creator A5046510449 @default.
• W4379283385 creator A5052552021 @default.
• W4379283385 creator A5056116159 @default.
• W4379283385 creator A5057399202 @default.
• W4379283385 creator A5059701114 @default.
• W4379283385 creator A5074318075 @default.
• W4379283385 creator A5077466283 @default.
• W4379283385 creator A5080215605 @default.
• W4379283385 creator A5085148558 @default.
• W4379283385 creator A5089670001 @default.
• W4379283385 date "2023-06-01" @default.
• W4379283385 modified "2023-09-25" @default.
• W4379283385 title "Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC)." @default.
• W4379283385 doi "https://doi.org/10.1200/jco.2023.41.16_suppl.e15155" @default.
• W4379283385 hasPublicationYear "2023" @default.
• W4379283385 type Work @default.
• W4379283385 citedByCount "0" @default.
• W4379283385 crossrefType "journal-article" @default.
• W4379283385 hasAuthorship W4379283385A5007831616 @default.
• W4379283385 hasAuthorship W4379283385A5017359496 @default.
• W4379283385 hasAuthorship W4379283385A5046510449 @default.
• W4379283385 hasAuthorship W4379283385A5052552021 @default.
• W4379283385 hasAuthorship W4379283385A5056116159 @default.
• W4379283385 hasAuthorship W4379283385A5057399202 @default.
• W4379283385 hasAuthorship W4379283385A5059701114 @default.
• W4379283385 hasAuthorship W4379283385A5074318075 @default.
• W4379283385 hasAuthorship W4379283385A5077466283 @default.
• W4379283385 hasAuthorship W4379283385A5080215605 @default.
• W4379283385 hasAuthorship W4379283385A5085148558 @default.
• W4379283385 hasAuthorship W4379283385A5089670001 @default.
• W4379283385 hasConcept C104317684 @default.
• W4379283385 hasConcept C121608353 @default.
• W4379283385 hasConcept C124535831 @default.
• W4379283385 hasConcept C126322002 @default.
• W4379283385 hasConcept C142724271 @default.
• W4379283385 hasConcept C143998085 @default.
• W4379283385 hasConcept C2776175330 @default.
• W4379283385 hasConcept C2777214474 @default.
• W4379283385 hasConcept C2778019345 @default.
• W4379283385 hasConcept C2779742787 @default.
• W4379283385 hasConcept C2781197716 @default.
• W4379283385 hasConcept C46111723 @default.
• W4379283385 hasConcept C502942594 @default.
• W4379283385 hasConcept C55493867 @default.
• W4379283385 hasConcept C71924100 @default.
• W4379283385 hasConcept C86803240 @default.
• W4379283385 hasConceptScore W4379283385C104317684 @default.
• W4379283385 hasConceptScore W4379283385C121608353 @default.
• W4379283385 hasConceptScore W4379283385C124535831 @default.
• W4379283385 hasConceptScore W4379283385C126322002 @default.
• W4379283385 hasConceptScore W4379283385C142724271 @default.
• W4379283385 hasConceptScore W4379283385C143998085 @default.
• W4379283385 hasConceptScore W4379283385C2776175330 @default.
• W4379283385 hasConceptScore W4379283385C2777214474 @default.
• W4379283385 hasConceptScore W4379283385C2778019345 @default.
• W4379283385 hasConceptScore W4379283385C2779742787 @default.
• W4379283385 hasConceptScore W4379283385C2781197716 @default.
• W4379283385 hasConceptScore W4379283385C46111723 @default.
• W4379283385 hasConceptScore W4379283385C502942594 @default.
• W4379283385 hasConceptScore W4379283385C55493867 @default.
• W4379283385 hasConceptScore W4379283385C71924100 @default.
• W4379283385 hasConceptScore W4379283385C86803240 @default.
• W4379283385 hasIssue "16_suppl" @default.
• W4379283385 hasLocation W43792833851 @default.
• W4379283385 hasOpenAccess W4379283385 @default.
• W4379283385 hasPrimaryLocation W43792833851 @default.
• W4379283385 hasRelatedWork W2065341885 @default.
• W4379283385 hasRelatedWork W2531151695 @default.
• W4379283385 hasRelatedWork W2766588635 @default.
• W4379283385 hasRelatedWork W2791800235 @default.
• W4379283385 hasRelatedWork W2795772359 @default.
• W4379283385 hasRelatedWork W2803171320 @default.
• W4379283385 hasRelatedWork W2943454415 @default.
• W4379283385 hasRelatedWork W2979107195 @default.
• W4379283385 hasRelatedWork W3032621101 @default.
• W4379283385 hasRelatedWork W3092792116 @default.
• W4379283385 hasVolume "41" @default.
• W4379283385 isParatext "false" @default.
• W4379283385 isRetracted "false" @default.
• W4379283385 workType "article" @default.